HBOT Conversations:
Laurie Anderson (Part 2)
Healing COVID with HBOT
Dr. Laurie is a Doctor of Pharmacy, and a graduate of the University of North Carolina – Chapel Hill (UNC-CH) School of Pharmacy and the Pharmacy Practice Residency Program at the University of California – San Francisco (UCSF). Dr. Laurie spent many years in clinical practice, first as a neurosurgery clinical pharmacist at UCSF Medical Center and then as a general medicine and critical care clinical pharmacist at Duke Medical Center. For the past 14 years Dr. Laurie has been working in industry, and is currently a safety scientist in early phase drug development, designing safety strategies for First Time in Human clinical trials.
Through her own journey navigating chronic illness, Dr. Laurie has explored and embraced many forms of alternative and non-traditional medicine to support her body for healing. She has gravitated towards practitioners and modalities that treat the whole patient, with the mantra that tending to mind, body and spirit is the true key to lasting health. Over the years, Dr. Laurie has discovered that this often leads to a ‘less is more’ approach. She discovered HBOT when she was struggling to heal from COVID, and now tells anyone who will listen about the power of oxygen and pressure.
Watch the Podcast
We continue Dr. Laurie Anderson’s HBOT News Network interview, diving in deeper to Hyperbaric Oxygen Therapy to heal COVID, and we bring up her struggles with Lyme Disease. Her interview is being released as a three part series, with Part 1 being released last week.
This podcast starts with our host, Ed di Girolamo, explaining to the audience that he and Dr. Laurie had a brief conversation before the interview, and they discussed autoimmune diseases, or the mechanisms of autoimmune diseases, that would include inflammation or hypoxia. He askes Dr. Laurie if this was discussed in her schooling when she got her doctorate in pharmacology. She explained that it was certainly talked about, but she really started to understand the trajectory of an underlying inflammatory process when she got sick. To help her heal, she applied her own medical knowledge to her healing process, and explains —
“But that wasn’t a cornerstone of what we learned, and it really became a cornerstone of my own healing, that getting control of inflammation was the way that my immune system was going to ramp back up and that my body was going to heal, unequivocally. It was all about addressing that inflammation.”
di Girolamo explains that years ago he attended a medical conference in Albuquerque that was specific to hyperbaric oxygen therapy, and he was on the edge of his seat for all three days. It was then that he started to truly understand how to read the science of HBOT. He brings up Lyme disease, which Dr. Laurie has personally struggled with, and recalls that there was a group of people there who have done HBOT and we’re so passionate in pushing it to help with Lyme disease because hyperbarics helped them, and they believe in it. di Girolamo states that through speaking to the medical profession about HBOT and Lyme, he has learned that Lyme disease is a virus and by doing a certain protocol of HBOT you’re essentially feeding the virus so much oxygen that it basically can not survive anymore and you “drown it”.
As the conversation progresses about Lyme disease, Dr. Laurie lists some symptoms and how HBOT helped her with tremendously with sleeping. After her first treatment she slept for 12 hours, which was unheard of for her. And she recalls that it was a very deep and refreshing sleep. She struggled for years and years with sleep from Lyme disease. Back then, HBOT was on the table as an alternative method of healing but she was only introduced to the mono-chambers and due to her extreme claustrophobia, it was not a healing avenue she wanted to explore at that time. She is thankful for the large multi-place chambers at Extivita that allowed Dr. Laurie to take a leap of faith and finally try HBOT.
Dr. Laurie’s career involves her reviewing the safety of clinical trials daily, so she explains that in order for a trial or study to be safe and effective, dosage is critical. di Girolamo explained that it’s the same for HBOT…. the right dosage of oxygen + pressure is critical to having healing success. He mentioned the podcasts with Dr. Stevens & Dr. Harch, as they both spoke in depth about dosage for hyperbaric oxygen therapy, especially for the indications that are considered to be “off label” for treatment with HBOT. Every person is unique and what works for one might not work the same for the next, so dosage can be tricky. But, in the end di Girolamo explains —
“I think at least in my conclusion, my humble opinion, is that any hyperbaric oxygen is better than no hyperbaric oxygen.”
Dr. Laurie referred to HBOT as a gift, because all that oxygen does so much for your brain. Which is exactly where it’s been proven to help veterans heal from PTSD, depression, anxiety, and even TBIs. She stresses that the mind-body connection is so strong, but it’s not talked about like it should be. In her opinion, she thinks that all that oxygen is strengthening the mind-body connection to the point where the brain is receiving that surge of oxygen and basically then signal the body that it’s ok…. let’s heal.
Stay tuned next week for Part 3 of Dr. Laurie’s podcast.
Guests
Dr. Laurie Anderson, Pharm.D.
Through her own journey navigating chronic illness, Dr. Laurie has explored and embraced many forms of alternative and non-traditional medicine to support her body for healing. She has gravitated towards practitioners and modalities that treat the whole patient, with the mantra that tending to mind, body and spirit is the true key to lasting health. Over the years, Dr. Laurie has discovered that this often leads to a ‘less is more’ approach.
When not working, Dr. Laurie is an avid gardener, ballroom dancer and traveler with her husband. Remaining curious and finding joy in every day are her super powers.
Subscribe Now, It’s Free!
Recent HBOT News
Clinical Trial – Intrathecal Neostigmine for Prevention of PDPH
Neuraxial blocks continue to be the cornerstone of anesthesia and postoperative analgesia for
normal vaginal delivery and elective caesarean section due to its approved safety and
efficiency for decades. Post-dural puncture headache (PDPH) is still one of the most common
complications of neuraxial anesthetic techniques. The headache could be severe and limit the
activities of the new mother to care for her baby, prolong hospital stay.
PDPH is defined as a headache that develops within five days of dural puncture and can’t be
attributed to any other types of headache and mostly is postural in character.
Neostigmine methylsulfate is a synthetic carbamic acid ester which reversibly inhibits the
enzyme Acetylcholine esterase (AChE) that makes more Acetylcholine molecules available at
cholinergic receptors. Neostigmine is used in anesthesia mainly as a reversal for
non-depolarizing neuromuscular agents.
Intrathecal (IT) neostigmine was tried as an adjuvant to local anesthetics in IT block for
elective cesarean sections to decrease local anesthetic consumption and to prolong
postoperative analgesia. Side effects of IT neostigmine are dose-dependent with doses more
than 25 µg especially nausea and vomiting and could be decreased by increasing the baricities
of the local anesthetic solutions and by early head up position after IT injection. However,
its effect on PDPH was not investigated before in literature.
Parturients will be randomly assigned into one of two groups: the intervention group will
receive 20 µg with IT Bupivacaine and the control group will receive an equivalent volume of
dextrose 5% with the IT Bupivacaine.
The objective of the current study is to evaluate the efficacy and safety of IT neostigmine
as an adjuvant to bupivacaine in reducing the incidence and severity of post-dural puncture
headache in parturients scheduled for an elective cesarean section.
Evidence brief: hyperbaric oxygen therapy (HBOT) for traumatic brain injury and/or post-traumatic stress disorder.
This report is a product of the VA Evidence-based Synthesis Program. The purpose is to provide “timely and accurate syntheses of targeted healthcare topics. to improve the health and healthcare of Veterans”. The authors have made a comprehensive search and analysis of the literature and make recommendations to assist clinicians in dealing with veterans suffering from either traumatic brain injury (TBI) or post-traumatic stress disorder (PTSD). The report is timely and of great potential impact given the vigorous and lengthy debate among hyperbaric physicians and lay people determined to find an answer for the large numbers of veterans deeply affected with some combination of PTSD and post-concussion dysfunction.
Clinical Trial – Hyperbaric Oxygen Therapy in Children With Inflammatory Bowel Diseases
The study assesses the effectiveness of hyperbaric oxygen therapy in the treatment of
inflammatory bowel disease in children.